
	Three Months Ended September 30,					Nine Months Ended September 30,
	2026		2025				2026			2025
Numerator:
Net income (loss)	$	4,677	$	(12,810	)		$	(8,364	)	$	(9,708	)
Denominator:
Weighted average common shares outstanding, basic		30,617		29,338				30,463			28,995
Dilutive effect of:
Stock plans		878		—				—			—
Convertible notes		—		—				—			—
Weighted average common shares outstanding, diluted		31,495		29,338				30,463			28,995

Net income (loss) per share — basic	$	0.15	$	(0.44	)		$	(0.27	)	$	(0.33	)
Net income (loss) per share — diluted	$	0.15	$	(0.44	)		$	(0.27	)	$	(0.33	)

Basic net earnings (loss) per share is calculated using our net earnings (loss) and our weighted average outstanding common shares.

Diluted net earnings (loss) per share is calculated using our net earnings (loss) attributable to common stockholders with interest charges applicable to our convertible debt added back under the if converted method, if dilutive, and our weighted average outstanding common shares including the dilutive effect of stock awards and employee stock purchase plan shares as determined under the treasury stock method and of our convertible notes using the if converted method, if dilutive. In periods when we recognize a net loss, we exclude the impact of outstanding stock awards and the potential share settlement impact related to our convertible notes from the diluted loss per share calculation as their inclusion would have an antidilutive effect.

The following table presents the outstanding shares of our common stock equivalents excluded from the computation of diluted net earnings (loss) per share as of the dates presented because their effect would have been antidilutive (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Stock options		—		472		372		472
RSUs, MSUs and PSUs		36		1,056		1,127		1,056
Employee stock purchase plan shares		20		18		20		18
2021 Notes		9		878		9		878
2025 Notes		711		711		711		711